Cargando…

Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies

SIMPLE SUMMARY: The response to neoadjuvant treatment is strongly associated with the clinical outcome of breast cancer patients, especially in the HER2-positive subtype of the disease. In HER2-positive patients with a residual tumor burden, an escalation of post-neoadjuvant therapy leads to the imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Krawczyk, Natalia, Fehm, Tanja, Ruckhaeberle, Eugen, Brus, Laura, Kopperschmidt, Valeria, Rody, Achim, Hanker, Lars, Banys-Paluchowski, Maggie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221124/
https://www.ncbi.nlm.nih.gov/pubmed/35740667
http://dx.doi.org/10.3390/cancers14123002